InSilico Medicine

Our mission statement and our pledge to our investors, friends and families: Through excellence in knowledge management, machine learning and bioinformatics, relentless pursuit for new drug, omics and clinical outcomes data, development of reliable in silico drug screening methods, novel validation approaches and strong international partnerships in personalized medicine we strive to find real working solutions to cure and prevent age-related diseases and aging itself. This mission will be achieved within within the regulatory frameworks as well as the legal and ethical boundaries and by working with the outstanding scientists, academic and medical institutions and pharmaceutical companies of impeccable credibility. Our goals are: to become the first and the largest drug discovery company in aging and age-related diseases; to become the first company to fully implement the concept of personalized science, where medicine is developed, tested and validated for individual patients in a safe high-throughput environment.
Company Growth (employees)
Type
Private
HQ
Baltimore, US
Founded
2014
Size (employees)
18 (est)+6%
InSilico Medicine was founded in 2014 and is headquartered in Baltimore, US

InSilico Medicine Office Locations

InSilico Medicine has an office in Baltimore
Baltimore, US (HQ)
b301 Johns Hopkins University Eastern Campus 1101 E 33rd St

InSilico Medicine Financials and Metrics

Summary Metrics

Founding Date

2014

Total Funding

$10 m

Latest funding size

$10 m

Time since last funding

8 months

Investors

InSilico Medicine's latest funding round in February 2017 was reported to be $10 m. In total, InSilico Medicine has raised $10 m

Traffic Overview of InSilico Medicine

InSilico Medicine Online and Social Media Presence

InSilico Medicine Company Life and Culture

You may also be interested in